Posted By: HGG Advances HGGA: What motivated you to start working on this project? SM: Working with the Vanderbilt University Undiagnosed Diseases Network (UDN) team during my PhD demonstrated the critical need for better approaches to variant interpretation in rare diseases. And even after a candidate gene and variant are identified, I observed that the... Read More
Published: August 17, 2022, 10:45 a.m. U.S. Eastern Time Media Contact: Kara Flynn, (202) 257-8424, press@ashg.org ASHG with generous support from National Human Genome Research Institute (NHGRI), Biogen, GlaxoSmithKline (GSK), Merck & Co., Inc, and Roche, is pleased to recognize this year’s Scholars. The Human Genetics Scholars Initiative was developed to help advance diversity and... Read More
Posted By: Sara Cullinan, PhD, Deputy Editor, AJHG SC: What motivated you to start working on this project? HT: Finding faults within the DNA sequences and learning their associations with disease has always piqued my interest. Our lab studies the genomic basis of complex hematological syndromes and particularly the pathogenic effect of a genetic variant... Read More
Posted By: HGG Advances HGGA: What motivated you to start working on this project? EJ: I wanted to obtain further insights into the genetics of the Greenlandic population, as it is a genetically unique and understudied population. Specifically, we sought to look further into a range of cardiometabolic phenotypes. The end goal was to improve... Read More
Media Contact: Kara Flynn, 202.257.8424, press@ashg.org For Immediate Release: Wednesday, July 20, 2022, 10:00 a.m. U.S. Eastern Time ASHG is proud to announce the recipients of its 2022 annual awards, which honor outstanding scientific achievements as well as significant contributions to genetics and genomics education, mentorship of the next generation, and application of research for the common... Read More
ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy